C12N 2760/18841
Use of virus, viral particle or viral elements as a vector
C12N2760/18841 (Use of virus, viral particle or viral elements as a vector) appears on 66 US grants and 155 published applications in this corpus.
Search patents in C12N- Granted patents
- 66
- Published applications
- 155
- Assignees
- 75
- Inventors
- 264
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 6 |
| 2003 | 2 | 5 |
| 2004 | 3 | 6 |
| 2005 | 0 | 7 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 3 | 6 |
| 2009 | 2 | 5 |
| 2010 | 2 | 8 |
| 2011 | 1 | 5 |
| 2012 | 2 | 4 |
| 2013 | 2 | 2 |
| 2014 | 0 | 3 |
| 2015 | 3 | 3 |
| 2016 | 1 | 8 |
| 2017 | 2 | 5 |
| 2018 | 2 | 5 |
| 2019 | 4 | 7 |
| 2020 | 6 | 9 |
| 2021 | 5 | 4 |
| 2022 | 3 | 12 |
| 2023 | 2 | 10 |
| 2024 | 5 | 7 |
| 2025 | 8 | 16 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cell culture vessel and method for culturing cell5 May 2026US 12,618,037 B2Fanuc Corporation
- Method for producing induced pluripotent stem cells20 Jan 2026US 12,529,035 B1National University Corporation Kobe University
- Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent13 Jan 2026US 12,521,358 B2RaQualia Pharma Inc.
- Methods of using Zscan4 for rejuvenating human cells25 Nov 2025US 12,478,657 B2Elixirgen Therapeutics, Inc.
- Methods of using ZSCAN4 for rejuvenating human cells25 Nov 2025US 12,478,659 B2Elixirgen Therapeutics, Inc.
- Vaccine with reduced anti-vector antigenicity24 Sep 2026US 2026/0284178 A1
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
- Methods of using zscan4 for rejuvenating human cells11 Jun 2026US 2026/0158105 A1Elixirgen Therapeutics, Inc.
- Composition and Use Method Therefor14 May 2026US 2026/0131027 A1Nanjing Reju Therapeutics, Co., Ltd.
Most cited
By later US patents
- Infectious Sindbis virus vectors121US 5,217,879 AWashington University · 1993
- Paramyxovirus vectors used for transfer of foreign genes13US 6,746,860 B1DNAVEC Research Inc. · 2004
- Process for preparation of cytokines using Sendai virus expression system12US 6,514,728 B1Nippon Biocaptal Limited · 2003
- Negative strand RNA viral vector having autonomous replication capability12US 6,645,760 B2DNAVEC Research Inc. · 2003
- Negative strand RNA viral vector having autonomous replication capability12US 6,723,532 B2DNAVEC Research Inc. · 2004